Regorafenib-d 3

Overview

Regorafenib -d 3 (BAY 73-4506-d 3 ) is a deuterium labeled Regorafenib ( HY-10331 ). Regorafenib is a multi-targeted receptor tyrosine kinase inhibitor.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > VEGFR | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > PDGFR | Products > Signaling Pathways > Raf | Products > Signaling Pathways > RET

Product Information

• Catalog No.: HY-10331S
• CAS No.: 1255386-16-3
• Molecular Formula: C21H12D3ClF4N4O3
• Molecular Weight: 485.83
• Purity: 98.0%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (5.15 mM); Clear solution
• Availability: In-stock

Source

Original product source